Dexmedetomidine for Shivering

Phase-Based Progress Estimates
3
Effectiveness
3
Safety
Shivering+1 MoreDexmedetomidine - Drug
Eligibility
18+
Female
What conditions do you have?
Select

Study Summary

This trial is testing whether a common sedative can help stop shivering during surgery.

Eligible Conditions
  • Shivering
  • Dose Finding Study

Treatment Effectiveness

Effectiveness Progress

3 of 3
This is further along than 93% of similar trials

Similar Trials

1
Dexmedetomidine
1
Dexmedetomidine
1
Dexmedetomidine Intranasal

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: During intraoperative course

5 minutes after administration of the drug
Shivering will be graded using a five-point scale as outlined by Crossley and Mahajan
During intraoperative course
Doses of dexmedetomidine
Maternal Heart Rate

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Similar Trials

1
Dexmedetomidine
2
Dexmedetomidine
1
Dexmedetomidine Intranasal

Side Effects for

Dexmedetomidine
57%Clinically important hypotension
9%Clinically important bradycardia
1%Atelectasis
1%stroke
1%infection
1%Hemorrhage
This histogram enumerates side effects from a completed 2020 Phase 4 trial (NCT02004613) in the Dexmedetomidine ARM group. Side effects include: Clinically important hypotension with 57%, Clinically important bradycardia with 9%, Atelectasis with 1%, stroke with 1%, infection with 1%.

Trial Design

1 Treatment Group

Dexmedetomidine
1 of 1

Experimental Treatment

40 Total Participants · 1 Treatment Group

Primary Treatment: Dexmedetomidine · No Placebo Group · Phase 4

Dexmedetomidine
Drug
Experimental Group · 1 Intervention: Dexmedetomidine · Intervention Types: Drug
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dexmedetomidine
FDA approved

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: during intraoperative course

Who is running the clinical trial?

Mayo ClinicLead Sponsor
2,917 Previous Clinical Trials
3,506,848 Total Patients Enrolled
Hans Sviggum, MDPrincipal InvestigatorMayo Clinic

Eligibility Criteria

Age 18+ · Female Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are pregnant with a baby whose gestational age is between 28 and 42 weeks.
Women presenting for planned cesarean delivery should be offered spinal anesthesia.
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top